// November 27, 2023
Q&A: Building a More Resilient Medicines Supply Chain
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
The development of generic versions of innovator medicines is a global public health need.
For nearly 200 years, USP’s public standards have served to establish a common foundation upon wh
We live in an age where the use of computers and software systems are directly integrated into th